
Legal
Sales Reps v. Pharma: What the Overtime Case Could Mean for Pharma
The Supreme Court's Decision on whether sales reps should qualify for the 'outside sales exemption' could have far reaching implications for pharma, write Lisa A. Schreter and Kimberly J. Gost ...Read more

Companies
Dare to Compare: Genzyme Bets on MS
Riding positive data on a late-phase multiple sclerosis drug, Genzyme execs talked up the company’s MS franchise and willingness to go head-to-head against Rebif, EMD Serono and Pfizer’s blockbuster beta interferon ...Read More
Case Study: How a Biotech Saved $600,000 on a CRO Contract
Download a new case study to discover how a small biotech applied innovative eClinical software to:
* Save $600,000 on a single Phase II outsourcing contract
* Compress the contracting cycle-time from three months to two weeks
* Form a more constructive and collaborative working relationship with their CRO
Download Now |
 |
Regulatory
FDA Addresses Globalization
A new report details the strategies, programs, and other activities the Agency is using to address the rise of imported pharmaceutical products ...Read More
Global
Europe Responds to Troubled Medical Devices Sector
EU health ministers have stepped carefully around medical devices, but the recent scandal concerning breast implants has the European Parliament baying for action. As a result, no pharmaceutical executive should ignore what happens in the sector over the coming months, says Reflector
...Read more

Special Feature
Finding Success in Pharma as a Woman or Minority Professional
Go global. Broaden your industry exposure. Think beyond yourself. And create a strategic plan around the most important product: you. Timely advice from this year's HBA Woman of the Year, Carolyn Buck Luce ...Read more |